REMOVAL OF CINACALCET (SENSIPAR) FROM THE PHARMACEUTICAL BENEFITS SCHEME (PBS)
Position Statement: approved June 2015
The statement outlines the situation regarding the recent changes to Cinacalcet (Sensipar) and a PBS subsidy. Read full statement>
ORGAN DONATION TRAFFICKING AND TRANSPORT TOURISM
Position Statement: approved November 2013
Kidney Health Australia completely supports The Declaration of Istanbul on Organ Trafficking and Transplant Tourism
which includes condemning the practice of buying and selling organs for transplantation and other illegal activities related to transplant tourism. See also Policy and Advocacy>
THE ASSOCIATION BETWEEN SUGAR SWEETENED SOFT DRINK & CHRONIC KIDNEY DISEASE
Position Statement: approved December 2014
Regular consumption of sugar-sweetened soft drinks is associated with the development of CKD and kidney stone formation. Kidney Healthy Australia supports the Consensus Statement published by Cancer Council Australia, Diabetes Australia and the National Heart Foundation of Australia, which recommends adults and children limit their consumption of sugar-sweetened beverages and instead drink water or reduced-fat milk. Read full statement>
Kidney Health Australia is a partner in Rethink Sugary Drink GroupWATER FLUORIDATION
Kidney Health Australia is passionate about reducing the amount of sugary drinks consumed by the Australian public. Drinks containing sugar may cause or worsen health related problems and should therefore be avoided and replaced with water.
Position Statement: last review approved September 2011
Kidney Health Australia - Position Statement on Water Fluoridation September 2011
National Kidney Foundation (USA) updated Fluoride Position Statement for people with CKD April 2008
DRINK WATER INSTEAD
Position Statement: last review June 2008 - read here>
As a result of Initial review in 2003, our Board adopted the following position in regard to water intake.
There is a lack of evidence that drinking water in excess of thirst is beneficial for the health of Australians living in temperate regions and not exercising strenuously.
The daily fluid intake needs are increased in:
all residents in tropical or hot climates
individuals practising strenuous exercise
certain medical conditions characterised by excess obligatory fluid loss
certain medical conditions requiring an increased urine flow
The daily fluid intake needs are decreased in most patients with:
From the kidney viewpoint, all fluids including those containing caffeine and alcohol should count towards your daily fluid total.
Patient Perspectives on dialysis: First National Census
Results and details of this first national census of patient perspectives on dialysis in Australia are contained in these reports.
State of the Nation - Chronic Kidney Disease in Australia May 2015
This 2015 report paints a striking picture of Australia’s kidney health, highlighting kidney disease as a silent killer which goes largely undiagnosed, and often works in partnership with cardiovascular disease and diabetes. The report highlights two confronting facts: less than 10% of Australians with Chronic Kidney Disease realise they have it; and 51% of people with CKD also have cardiovascular disease or diabetes. The report highlights that 6 out of 10 people with CKD have hypertension, but sadly 96% of Australian adults are unaware of the link between high blood pressure and kidney disease. Compare: State of the Nation 2014>
CKD Priorities Summary Workshop Report April 2014
Resulting from a national workshop in February 2014 in Sydney, to explore research priorities in chronic kidney disease, this report provides an overview of participants, the process and preliminary results.
The KinD Report Kidneys in Diabetes) Report April 2014
Temporal trends in the epidemiology of diabetic kidney disease and the associated health care burden in Australia.
Produced by Dr Sarah White and Professor Steve Chadban at Kidney Research Node, Royal Prince Alfred Hospital & University of Sydney for Kidney Health Australia.
Two of a KinD (Kidneys in Diabetes) Report 2011
The burden of diabetic kidney disease and the cost-effectiveness of screening people with type 2 diabetes for chronic kidney disease. The KinD Report - Summary 2011
Australian Guidelines for the management of absolute cardiovascular disease risk
National Vascular Disease Prevention Alliance (NVDPA) May 2012
Absolute cardiovascular risk is the numerical probability of a cardiovascular event occurring within five years, expressed as a percentage. Online risk calculator cvdcheck.org.au * Absolute Risk videos
ISBN: 978-0-9872830-1-6 © National Stroke Foundation 2012. Initiative of National Vascular Disease Prevention Alliance:
Diabetes Australia, Kidney Health Australia, National Heart Foundation of Australia & National Stroke Foundation
Economic Impact of End-Stage Kidney Disease in Australia - Projections to 2020
Contributors: Alan Cass, Steven Chadban, Martin Gallagher, Kirsten Howard, Alexandra Jones, Stephen McDonald, Paul Snelling and Sarah White. November 2010.
The cost of treating end-stage kidney disease from 2009 to 2020 is estimated to be around $12 billion to the Australian Government. This reports reveals the incidence of kidney disease is growing at a serious rate, projected to increase by more than 54% to 2020. Report estimates that increasing the use of home dialysis over the next 10 years would lead to an estimated net savings of between $378 and $430 million for our health system. Annual costs per person for home dialysis is $49,137, compared to $79,072 for hospital dialysis. Read full report>
The Economic Impact of End Stage Kidney Disease in Australia
Contributors: Alan Cass, Steven Chadban, Jonathan Craig, Kirsten Howard, Stephen McDonald, Glenn Salkeld and Sarah White. Released December 2006.
The report outlines the future projected costs associated with providing renal replacement therapy, as well as the benefits in terms of quality of life. In addition, the report predicts the financial impact of increasing the availability of kidney transplantation to internationally acceptable levels, and varying the uptake of out-of-hospital dialysis therapies.
The Cost-effectiveness of Early Detection and Intervention to Prevent the Progression of Chronic Kidney Disease in Australia
Contributors: Kirsten Howard, Glenn Salkeld, Sarah White, Steven Chadban, Jonathan Craig, Stephen McDonald, Vlado Perkovic and Alan Cass. Released December 2006.
This report provides the first assessment of the impact of early detection and intervention strategies to prevent the progression of CKD in Australia. The report estimates the cost-effectiveness of opportunistic screening (testing for CKD when someone visits a GP for another reason) and best-practice management of diabetes, high blood pressure and protein in the urine, in Australian adults.
CKD and automatic reporting of estimated glomerular filtration rate: new developments: revised
Johnson DW, Jones GRD, Mathew TH et al. Med J Aust 2012;197(4):222-3.
CKD and measurement of albuminuria or proteinuria: a position statement
Johnson DW, Jones GRD, Mathew TH et al. Med J Aust 2012;197(4):224-5.
Renal unit characteristics and patient education practices that predict a high prevalence of home-based dialysis in Australia Fortnum D, Ludlow M, Morton RL. Nephrology 2014;19:587-93.
How Australian nephrologists view home dialysis: Results of a national survey
Ludlow MJ, George CRP, Hawley CM et al. Nephrology 2011;16:446-52.
Australian Nephrology Nurses Views on Home Dialysis: A National Survey
Lauder LA, Ludlow MJ, Hawley CM, Richardson EP, Mathew TH, Munro CE. Ren Soc Aust J 2011;7(1):6-12.
Review: Early detection of chronic kidney disease in Australia: Which way to go?
Mathew T, Corso O. Nephrology 2009;14:367-73.
Screening for chronic kidney disease in Australia: a pilot study in the community and workplace
Mathew TH, Corso O, Ludlow M et al. Kidney International 2010;77(Suppl 116):S9-S16.
For more AIHW reports go to:
Chronic Kidney Disease
(ABS) *Indigenous Australians
& Indigenous Health Risk Factors
Cardiovascular disease, diabetes and chronic kidney disease: Australian facts: Risk factors
AIHW - Released March 2015: This report on risk factors presents the latest statistics on the behaviours and characteristics that increase the likelihood of a person developing these chronic diseases. It also describes the risk factors among people who already have CKD, diabetes and CKD. It examines age and sex characteristics and variations across population groups, including by geographical location and socioeconomic disadvantage.
Cardiovascular disease, diabetes and chronic kidney disease - Australian facts: Morbidity - Hospital Care
AIHW - Released December 2015: This report on risk factors presents the latest statistics on the behaviours and characteristics that increase the likelihood of a person developing these chronic disease. It also describes risk factors among people who already have CVD, diabetes or CKD. It examines age and sex characteristics and variations across population groups, including by geographical location and socioeconomic disadvantage.
Cardiovascular disease, diabetes and chronic kidney disease - Australian facts: Prevalence and incidence
AIHW - Released November 2014: This report on prevalence and incidence provides a comprehensive summary of the latest available data on the prevalence and incidence in the Australian population of these three chronic vascular diseases, acting alone or together. It examines age and sex characteristics and variations across population groups, by geographical location, and by socioeconomic disadvantage.
Cardiovascular disease, diabetes and chronic kidney disease: Australian facts mortality
AIHW - Released October 2014: This report on Mortality presents up-to-date statistics as well as trends on deaths from these chronic diseases. It examines age and sex characteristics, and variations across population groups, including among Aboriginal and Torres Strait Islander people, by geographical location, and by socioeconomic disadvantage.
Chronic kidney disease: Regional variation in Australia
AIHW - Released October 2013: Chronic kidney disease is a common and serious problem in Australia and its management can be resource intensive, particularly for the most severe form of the disease: end-stage kidney disease. Rates of chronic kidney disease vary by geographic location. This report shows: people from remote and very remote areas, were 2.2 times more likely to die from chronic kidney disease than people from Major cities. - people from Very remote areas were at least 4 times more likely to start kidney replacement therapy (dialysis or kidney transplant) than people from non-remote areas.
Projections of the incidence of treated End-Stage Kidney Disease in Australia, 2010-2020
AIHW - Released September 2011: This report presents national level projections of the number of people receiving kidney replacement therapy for their ESKD for the period 2010 to 2020. This information is important for predicting the future burden of ESKD in Australia.
Chronic kidney disease in Aboriginal and Torres Strait Islander people
AIHW - Released September 2011: This report presents the first detailed analysis of chronic kidney disease in Aboriginal and Torres Strait Islander people and how it compares to non-Indigenous Australians. Indigenous Australians have a greater burden of disease for many health conditions, and chronic kidney disease is no exception. Indigenous Australians were found to be more likely to have end-stage kidney disease, and be hospitalised or die with chronic kidney disease than non-Indigenous Australians.
The Renal Drug Reference Guide
Guide intended for healthcare professionals who can exercise independent professional clinical judgement when referring to content.
Following introductory principles on the use of drugs in patients with renal failure, this reference guide is structured into thirteen colour coded therapeutic chapters including: anaemia, analgaesia, antihistamines, anti-infectives, cardiovascular, endocrine and metabolic disorders, gastrointestinal, genitourinary, immunosuppressants, musculoskeletal, neurology & psychotropics. It is evidence based and practical advice, written expressly for the prescriber searching for easy to comprehend definitive advice.
Enquiries to author: Matthew Cervelli +61 408 846 901 or firstname.lastname@example.org
Do you have patients considering home dialysis? 1800 454 363
Access an online education resource site on home dialysis, including a developing area specifically for health professionals at our sister site homedialysis.org.au
- queries to email@example.com
My Kidneys - My Choice! Decision Aid Tool
Designed to support patients and their families through the education and decision making process, this tool is a supplement to education and not a replacement. This health professional guide will help you understand how the Decision Aid Tool was designed to be used in practice and contains useful hints and tips, as well as background information - download here>
Kidney Cancer Support Service - freecall 1800 454 363
Our sister site offers evidence based education for patients kidneycancer.org.au
Queries to firstname.lastname@example.org
KHA pages: Kidney Check Australia Taskforce I KHA-CARI Guidelines
Patient education resources: Kidney Health Resources I Organ Donation
Page updated 2 July 2015